# Edwards SAPIEN-3 Periprosthetic Leakage Evaluation Versus Medtronic CoreValve in Transfemoral Aortic Valve Implantation

> **NCT01982032** · NA · TERMINATED · sponsor: **UMC Utrecht** · enrollment: 56 (actual)

## Conditions studied

- Periprosthetic Aortic Valve Regurgitation After TAVI

## Interventions

- **PROCEDURE:** Transcatheter aortic valve replacement
- **DEVICE:** Medtronic CoreValve system
- **DEVICE:** Edwards SAPIEN bioprosthesis

## Key facts

- **NCT ID:** NCT01982032
- **Lead sponsor:** UMC Utrecht
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2013-11
- **Primary completion:** 2016-05
- **Final completion:** 2017-05
- **Target enrollment:** 56 (ACTUAL)
- **Why stopped:** slow enrollment, study device unavailable ( CoreValve)
- **Last updated:** 2018-11-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01982032

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01982032, "Edwards SAPIEN-3 Periprosthetic Leakage Evaluation Versus Medtronic CoreValve in Transfemoral Aortic Valve Implantation". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT01982032. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*